From this week’s cancer news we look at how HIV research could offer clues about lung cancer and bust headlines about a radiotherapy ‘cure’ for prostate cancer.
Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.
In this week's news a drug was approved for some lung cancer patients in England, and vaping could be a big piece of the quitting smoking puzzle.
A new recommendation by NICE gives certain lung cancer patients access to the immunotherapy drug nivolumab, through the Cancer Drugs Fund.
Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment
A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.
In this week's cancer news there's vitamin supplements and lung cancer risk, physical activity in middle age and immunotherapy research. Read our digest for more.
Researchers believe that focused high doses of radiotherapy could one day replace surgery for small cancers in certain organs.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found.
Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.